Search results
Spotlight! No. 3 (September 2026)
In the September issue of Spotlight!:
- Immunotherapy
Can you also fight skin tumors with deliberately induced vitiligo? - Section: Eye to Eye.
- My moment
Vitess Study
Amsterdam UMC (alongside Erasmus MC) has also started the Vitess study, a clinical trial into a new treatment for (non-segmental) vitiligo.
ruxolitinib cream
Important update regarding the reimbursement of ruxolitinib cream (brand name Opzelura)
On June 15, the final meeting took place between Zorginstituut Nederland, Vitiligo.nl, Huid Nederland, and the Dutch Association for Dermatology and Venereology (NVDV).
On behalf of everyone with vitiligo, we have once again made it clear that vitiligo is much more than a skin condition.
Vitess Study Erasmus MC
Erasmus MC, Rotterdam will shortly launch the Vitess study, a clinical trial into a new treatment for (non-segmental) vitiligo.
The personal story of Anny Silva
Anny Silva's personal story about her vitiligo,
Spotlight! No. 2 (June 2026)
In the June issue of Spotlight!:
- Nicoline van Buchem-Post, on her dissertation concerning, among other things, the various treatment methods for vitiligo.
- New column: Eye to Eye.
- Also new is our columnist Joost van Mier (36) from Tilburg.
- Research into disease activity by UZ Ghent, Belgium.
- Frank flies all over the world.
Vitiligo Patient Views
The Vitiligo International Patient Organizations Committee (VIPOC) is currently conducting a unique global study: Vitiligo Patient Views.
You wouldn't want to have that, Junior!
During World Vitiligo Day 2025 at the Noordermarkt in Amsterdam, our young hero Jans was followed for the program Je Zal Het Maar Hebben Junior.
I have vitiligo, what now?
Information meeting Bravis Hospital Bergen op Zoom.
This information meeting is intended to inform patients, their relatives, and referring physicians about the skin condition vitiligo, the possible treatment methods, and the psychosocial aspects.
General Meeting 2026
Invitation to the General Meeting 2026
NL
EN
FR
DE
ES